HVAX Technologies
Cleanroom and HVAC systems for life sciences, pharma and high-tech manufacturing.
Quality of growth, returns, cash conversion and balance sheet
Trend, momentum, volume and relative strength composite
Higher = cheaper vs peers and own history
Blended decision input
What's real, what's pending, on this page
- · Live price, day change, market cap — NSE direct
- · 1Y OHLCV, RSI(14), 50/200 DMA, 1M/3M/1Y returns, RS vs Nifty — computed from real NSE OHLCV
- · Sector P/E — NSE direct
- · Promoter %, pledge %, MF/FII/public split, 9-quarter history — Trendlyne
- · Earnings call AI summaries — Trendlyne (where available)
- · Technical (TQ-100) score — computed from real OHLCV
- · Annual revenue / EBITDA / PAT / OCF / FCF / equity / assets — Trendlyne (audited annuals)
- · Segment classification + semicon directness score — analyst seed
- · Bull/bear case + monitorables (curated thesis) — analyst seed
- · Governance risk score (seed) — being replaced by AI-agent assessment
- · Synthesized 5Y forecast removed entirely (was inaccurate)
Growth 20 / Margin 15 / ROC 20 / Cash 15 / Leverage 10 / Reinvestment 8 / Accounting 7 / Governance 5 minus red flags (capped -20).
- − Weak cash conversionOCF/EBITDA -80% < 50%-4
- − Governance risk elevatedRisk score 35/100-6
Computed from real 1Y OHLCV pulled from NSE direct: trend, momentum, volume, RS vs Nifty, MA cluster, mean reversion, volatility, patterns minus red flags.
AI research agents
Re-classify segment exposure and re-assess governance risk by running fresh AI agents on the latest data. Results cache to data/agents.json.
AI thesis
Generates a fresh thesis grounded in this company's data. Wires to Anthropic when ANTHROPIC_API_KEY is set, otherwise returns a deterministic mock.
Curated thesis
Analyst-set bull, bear and monitorables · use AI thesis above for a fresh take
Cleanroom/HVAC beneficiary of fab/OSAT capex with SME-tier risks.
- +Pharma + semicon cleanroom mix
- +Reasonable margins
- +Order book visibility
- −SME liquidity
- −Limited disclosure
- −Customer concentration
Semiconductor exposure
How direct, how visible
Financial snapshot
Latest reported metrics · mock data, ready for live financials
Extracted from Trendlyne · audited annuals · TTM + last 6 fiscal years
| Line | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹131 cr | ₹108 cr | ₹96 cr | ₹69 cr | ₹61 cr | ₹45 cr | ₹41 cr |
| ↳ YoY growth | +22.2% | +11.9% | +39.7% | +12.2% | +35.0% | +11.0% | — |
| EBITDA | ₹19 cr | ₹15 cr | ₹9 cr | ₹7 cr | ₹6 cr | ₹4 cr | ₹3 cr |
| ↳ EBITDA margin | 14.5% | 14.1% | 9.2% | 10.8% | 10.1% | 9.3% | 7.8% |
| PAT | ₹11 cr | ₹9 cr | ₹5 cr | ₹4 cr | ₹4 cr | ₹2 cr | ₹2 cr |
| ↳ PAT margin | 8.4% | 8.7% | 5.4% | 6.1% | 5.7% | 4.2% | 3.9% |
| OCF | ₹-22 cr | ₹-12 cr | ₹-4 cr | ₹-1 cr | ₹8 cr | ₹2 cr | ₹5 cr |
| ↳ OCF / EBITDA | -115.3% | -80.3% | -40.9% | -10.8% | 129.0% | 45.2% | 165.6% |
| FCF (= OCF − capex) | ₹-22 cr | ₹-14 cr | ₹-4 cr | ₹-1 cr | ₹4 cr | ₹1 cr | ₹-2 cr |
| Total Equity | ₹72 cr | ₹31 cr | ₹17 cr | ₹12 cr | ₹9 cr | ₹6 cr | ₹4 cr |
| Total Assets | ₹122 cr | ₹64 cr | ₹78 cr | ₹54 cr | ₹38 cr | ₹28 cr | ₹23 cr |
| ↳ ROE | 15.3% | 30.7% | 30.2% | 35.0% | 38.0% | 33.3% | 42.1% |
| ↳ ROA | 9.0% | 14.8% | 6.6% | 7.8% | 9.3% | 6.8% | 7.0% |
From Trendlyne · 9 quarters · synced Invalid Date
- ·Recently listed (SME)
- ·Promoter stable at 66.7%
- ·No pledge
Capital allocation, debt discipline, alignment, governance composite. Computed from disclosed metrics.
What the market is pricing in versus our read, and what would invalidate the thesis.
Steady but unspectacular execution. Multiples reflect mid-pack expectations.
The market is correctly cautious. Variant perception works against you here — wait for governance signals to clear.
- ×Working capital blowout disclosed in next quarterly result
- ×Project execution slip beyond stated commissioning date
- ×Auditor change, CFO exit, or RPT disclosure that requires explanation
References
Wire to live data sources in production